Disclosure and scope: This article combines documented facts with my own analysis as a social psychologist and as the patient whose complaint about access to female sterilisation in Oxfordshire exposed serious failures in NHS policy-making and complaint handling. Where I am offering an interpretation rather than reporting an established causal fact, I say so explicitly.
As a social psychologist, I spend a great deal of time thinking about how ideas spread. We tend to imagine social contagion as something obvious: a slogan goes viral, a political movement suddenly becomes fashionable, or a set of talking points appears everywhere at once. In reality, belief systems often travel much more quietly. They move through professional networks, think tanks, legal arguments, conferences, political relationships, religious communities, donor networks, media framing and repeated language that slowly makes one way of seeing the world feel normal.
That is one reason I have become increasingly concerned by what is happening to reproductive rights in the United States. Since the US Supreme Court overturned Roe v Wade in 2022, abortion access has become dramatically more dependent on where a woman lives. As of September 2026, the Guttmacher Institute reports that 13 US states have total abortion bans in effect and another 28 have gestational bans. The second Trump administration has also reinstated the Mexico City Policy and rescinded Biden-era executive actions intended to protect access to reproductive healthcare. Whatever one's personal views on abortion, this is plainly a large-scale political reorganisation of reproductive healthcare.
Britain is not America. Our legal system is different, our healthcare system is different, and public attitudes are different. But Britain and the United States have also spent more than 80 years describing their relationship as uniquely close. British governments call it the “special relationship”; the US government has described the UK as its closest ally. That closeness is not confined to defence. Ideas, campaign methods, legal strategies, political personnel, philanthropy and culture move across the Atlantic with unusual ease.
So when a well-funded US legal movement that helped shape the American reproductive-rights battles establishes a London presence, increases its UK spending, briefs MPs, supports litigation and builds relationships inside Westminster, I think the right question is not, “Are we becoming America tomorrow?” The right question is: what ideas are being normalised today, who is paying to normalise them, and what happens if we only notice after institutional practice has already shifted?
What does “social contagion” have to do with reproductive rights?
Social contagion does not mean that one country mechanically copies another. It means attitudes, narratives and behavioural models can spread through networks. Political movements learn from each other. Campaigners borrow language that has worked elsewhere. Legal organisations test arguments in one jurisdiction and adapt them to another. Politicians observe which issues mobilise supporters. Media ecosystems repeat frames until they become familiar.
In the United States, the abortion debate was not transformed overnight. It was the result of decades of organising: litigation, judicial appointments, state legislation, donor funding, activist mobilisation, religious campaigning and the construction of an intellectual and legal infrastructure capable of turning a long-term ideological objective into public policy. Dobbs v Jackson Women's Health Organization was the legal endpoint of a much longer political process.
This matters because one of the organisations embedded in that US legal infrastructure — Alliance Defending Freedom, or ADF — now has a substantial British operation.
Who is Alliance Defending Freedom, and why does its UK growth matter?
Alliance Defending Freedom is a US-founded Christian legal advocacy organisation. Its American operation is large: according to its 2024 US tax filing, reported by ProPublica's Nonprofit Explorer, it had revenue of approximately $110.7 million and expenditure of approximately $106.4 million. ADF has participated in major US litigation concerning abortion, religious liberty and LGBT rights. It was involved in the legal movement around Dobbs, the Supreme Court decision that removed the federal constitutional right to abortion.
ADF's international arm has built a presence in European centres of political and legal power, including London, Brussels, Strasbourg, Geneva and Vienna. Its UK entity, ADF International (UK), is a registered charity and company. The Charity Commission describes its charitable purpose as advancing Christianity and promoting Christian principles and ethics.
The financial trajectory is notable. ADF International UK's Charity Commission entry shows income of £1,468,307 and expenditure of £1,404,402 for the year ending 30 June 2025. The Guardian had previously reported that its spending rose from roughly £392,000 in 2020 to almost £1 million in the year to June 2023. This is no longer a tiny overseas campaign office operating at the edge of British political life. It is a seven-figure organisation with staff, lawyers, parliamentary relationships and an explicit advocacy strategy.
What does ADF say it is doing?
ADF presents its work as human-rights advocacy centred on religious freedom, freedom of speech, parental rights and protection of life. In Britain it has repeatedly framed disputes around abortion-clinic “buffer zones” or “safe access zones” as questions of free expression and religious freedom. It has supported or represented people accused of breaching restrictions around abortion clinics, and it has opposed efforts to decriminalise abortion.
That framing deserves to be represented accurately. ADF does not publicly describe itself as an organisation trying to import an American culture war. It says it is defending fundamental freedoms and the right to life. People who share those values may regard its work as principled civil-liberties advocacy.
Critics see something different: a sophisticated legal organisation using rights-based language to pursue an agenda that has historically included restricting abortion access and opposing LGBT rights. Those concerns are not based only on rhetoric. They arise from ADF's litigation record, its US political relationships and its expanding European presence.
How close has ADF UK come to British political power?
The answer is: close enough that it deserves serious public attention.
In 2024, The Guardian reported that ADF International UK had been producing policy briefings and legal analysis for MPs, including ahead of votes concerning buffer zones around abortion clinics. The newspaper also reported that ADF had been appointed as a stakeholder to a parliamentary group concerning freedom of religion or belief, and that in September 2023 it paid travel and accommodation costs for Fiona Bruce MP, then the Prime Minister's Special Envoy for Freedom of Religion or Belief, to attend a conference.
In April 2025, Baroness Bennett asked the Government what assessment it had made of the impact of lobbying by overseas-funded organisations such as ADF on UK human rights and democracy. The Government did not announce a specific investigation into ADF. Its answer instead pointed to ministerial transparency rules, parliamentary registers and rules governing all-party parliamentary groups.
That response is revealing in its own way. The existence of foreign-linked ideological advocacy inside Westminster is not hypothetical; it has become sufficiently visible to generate parliamentary questions about transparency and influence.
Is ADF the whole story?
No. Focusing exclusively on ADF would make the picture misleadingly simple. Britain's anti-abortion movement includes longstanding domestic organisations, parliamentary networks, religious groups, campaign organisations and newer transnational actors. Some are primarily British and funded largely through British supporters. Some have international ideological or organisational connections. They do not all share the same tactics or every policy position.
Right To Life UK: a direct parliamentary bridge
Right To Life UK is a British registered charity focused on abortion, assisted suicide and embryo research. It describes its mission as protecting human life from conception to natural death and says it works through education, politics, media and a network of supporters across the UK.
Its political role is unusually concrete. The official Parliamentary Register records that Right To Life UK acts as secretariat to the All-Party Parliamentary Pro-Life Group. As of February 2026, the APPG was chaired by DUP MP Carla Lockhart, with Baroness Eaton, Sir Desmond Swayne and Baroness Ritchie of Downpatrick among its officers. Right To Life UK itself says its public-affairs team supplies research, briefings and policy analysis to MPs and peers and has direct relationships with parliamentarians across parties.
Its financial scale is also significant. Charity Commission figures for the year ending March 2025 record income of £1,164,156 and expenditure of £1,231,188. Right To Life UK says it receives no government funding and is funded by supporter donations.
This is important because influence does not require secret meetings or conspiracies. An organisation that drafts briefings, provides an APPG secretariat, mobilises constituents to contact MPs, tracks voting records and maintains relationships with parliamentarians is describing ordinary, organised political advocacy. The democratic question is not whether advocacy should exist. Of course it should. The question is whether the public understands who is doing it, how well resourced they are, and how their goals fit into a broader ecosystem.
SPUC, 40 Days for Life and clinic-focused campaigning
The Society for the Protection of Unborn Children (SPUC) is one of Britain's oldest anti-abortion organisations. It has campaigned for decades against abortion and on related bioethical issues. Separately, the US-originated 40 Days for Life model — prayer vigils and activism around abortion clinics — has been adopted in Britain. OpenDemocracy has reported that British anti-abortion organiser Robert Colquhoun described being inspired by US counterparts and was credited by 40 Days for Life with helping export the model into the UK.
Again, the point is not that every British campaign is controlled from America. The more interesting and better-supported conclusion is that tactics, legal theories and movement know-how cross borders. Domestic organisations can remain domestically run while still participating in an international political culture.
How much money is moving through the wider European “anti-rights” ecosystem?
We should be careful with labels here. “Anti-rights” and “anti-gender” are terms used by organisations that monitor movements opposing abortion rights, LGBT rights, sex education and some gender-equality policies. The groups being described often reject those labels and instead describe themselves as pro-life, pro-family or defenders of religious freedom.
With that caveat, the scale documented by the European Parliamentary Forum for Sexual and Reproductive Rights (EPF) is substantial. Its 2021 report, Tip of the Iceberg, identified approximately $707 million in spending by a sample of organisations active across Europe between 2009 and 2018, including about $81 million originating from US actors. EPF's 2025 follow-up, The Next Wave, reported $1.18 billion in spending by anti-rights and anti-gender initiatives in Europe between 2019 and 2023.
These numbers do not mean that $1.18 billion was spent on British abortion lobbying, nor that all organisations in the dataset have identical aims. They do show that the European political environment around sexuality, reproduction and gender now includes a large, professionalised, transnational advocacy sector.
Why does the American example matter now?
Because the American movement demonstrates what long-term infrastructure can accomplish.
In June 2022, the Supreme Court decided Dobbs and overturned the constitutional framework created by Roe v Wade. By September 2026, Guttmacher counted 13 states with total abortion bans and 28 more with gestational bans. The legal conflict has also moved to medication abortion. Just this month, a federal appeals court has been considering another attempt by Republican-led states to restrict access to mifepristone, the drug used in most US abortions.
At federal level, President Trump in January 2025 ordered enforcement of the Hyde Amendment as administration policy and revoked two Biden executive orders designed to protect access to reproductive healthcare. On the same day, he reinstated the Mexico City Policy for overseas health assistance.
None of those developments proves that Britain will follow the same path. But they demonstrate that reproductive rights that appear politically settled can become unsettled when sufficiently organised movements acquire legal, political and institutional leverage.
But what does any of this have to do with female sterilisation?
This is where I want to be exceptionally clear.
I have found no evidence that ADF, Right To Life UK, SPUC or any other anti-abortion organisation caused the NHS restriction that affected my access to female sterilisation. I have also found no evidence that ADF lobbied NHS England to weaken national wording about the funding of female sterilisation.
I will not manufacture that connection merely because it would make a dramatic story.
My concern is about something broader: the political environment in which women's reproductive autonomy is interpreted. Reproductive freedom does not begin and end with abortion. It includes access to contraception, informed consent, the ability to continue a pregnancy, the ability to end one within the law, fertility care, and — for adults who do not want children — the ability to make a considered permanent choice not to become pregnant.
When a political culture becomes increasingly comfortable with the idea that institutions may override women's reproductive preferences “for their own good”, “for the unborn”, “because they may regret it”, “because another method is preferable”, or because access should depend on local policy, I pay attention. The arguments are not identical, but the underlying question of who gets final authority over reproductive decisions is connected.
What changed on the NHS website — and why do I consider it monumental?
The current NHS England information on female sterilisation says:
“Sterilisation may be available free on the NHS, or you may need to pay for your treatment.”
Read that next to the NHS's general contraception information, which states that contraception services are free and confidential on the NHS, and next to the NHS Constitution's principle that access to NHS services is based on clinical need rather than ability to pay.
The wording matters because female sterilisation is itself listed by the NHS as a method of contraception. It is more than 99% effective and does not affect hormones. Yet the national patient-facing page now explicitly tells women that this particular contraceptive option may not be funded where they live.
Older NHS-facing and NHS-derived information presented contraception much more straightforwardly as free on the NHS, and Sexual Health London material reviewed in 2020 stated directly that female sterilisation was available free on the NHS. The present national wording is therefore materially weaker than the expectation historically created around NHS contraception.
For me, this is not a cosmetic website edit. It is a public acknowledgement of a postcode lottery.
What does a postcode lottery look like in practice?
It means two women with the same reproductive wishes, similar clinical circumstances and equal capacity to provide informed consent may encounter different pathways because they live under different commissioners. One may be referred. Another may be required to try long-acting reversible contraception first. Another may discover that the service is not routinely commissioned. Another may be told she can pay privately.
That is precisely the kind of local variation that my own case forced me to confront. The Oxfordshire policy applied to me required women seeking sterilisation to use long-acting reversible contraception first, unless exceptions applied. My complaint was not simply that I disliked the answer. I challenged the evidential, equality and governance basis of a policy that restricted a permanent reproductive choice.
The Parliamentary and Health Service Ombudsman later found failures in the way the policy and my complaint had been handled. Yet the broader problem remains: a national health service can still allow local commissioning decisions to determine whether a fundamental reproductive option is practically available.
Is local commissioning automatically a violation of women's rights?
No. The NHS has finite resources, and Integrated Care Boards make local commissioning decisions across many services. Different clinical needs and local service structures can legitimately produce variation.
But that cannot be the end of the conversation. NHS England and ICBs also have statutory duties concerning equality and health inequalities. The NHS Constitution states that the service should be comprehensive, available to all, and that patients should not be refused access on unreasonable grounds. It also says care should reflect patients' needs and preferences.
So the real question is not whether any local variation may exist. It is: how much variation is acceptable when the service in question concerns bodily autonomy and reproductive decision-making, and what evidence must commissioners produce before restricting it?
Could Britain lose reproductive rights without ever announcing that it is doing so?
That is the question that worries me most.
Rights do not always disappear through a single dramatic Act of Parliament. Sometimes they become harder to exercise. A service stops being routinely commissioned. Eligibility criteria narrow. Waiting lists become prohibitive. A procedure remains technically legal but practically inaccessible. National wording shifts from “available” to “may be available”. Patients are redirected to private payment. The formal right survives while meaningful access erodes.
From a social-psychological perspective, this is also how norm change can occur: not necessarily by persuading everyone that a right should disappear, but by gradually changing what people accept as normal.
That is why I continue pressing the NHS for accountability long after my own individual complaint could have ended. I do not need to prove that an American organisation wrote an Oxfordshire sterilisation policy in order to be concerned about the wider environment. I need to show, carefully and document by document, where women's choices are being narrowed, who is lobbying political institutions on reproductive issues, what ideas are crossing borders, and whether the safeguards that are meant to protect equality and patient autonomy are actually working.
So, is Britain importing America's reproductive-rights culture war?
Not wholesale. Not inevitably. And not in the simplistic sense that Washington gives instructions and Westminster follows them.
But there is strong evidence that American organisations, money, legal strategies and campaign models are operating inside the British and European political environment. There is strong evidence that ADF's UK spending and Westminster activity have grown. There is strong evidence of organised parliamentary advocacy by domestic anti-abortion organisations. And there is undeniable evidence that the American reproductive-rights settlement once regarded as constitutionally secure was dismantled after decades of organised political and legal work.
For me, those facts justify vigilance, not conspiracy.
And when, at the same time, the national NHS website tells women that permanent contraception “may” be funded or they “may” have to pay, I think we should ask harder questions about what reproductive freedom actually means in Britain.
For a closer investigation of the organisations, funding, parliamentary relationships, litigation strategies and political machinery behind this movement, read my companion article: The American Anti-Abortion Movement Is Spending Money in Britain. What Does It Want?
References and further reading
- NHS. Finding out about female sterilisation. Current NHS England patient information; reviewed 14 February 2024.
- NHS. Where to get contraception. NHS patient information stating that contraception services are free and confidential on the NHS.
- Department of Health and Social Care. The NHS Constitution for England and accompanying handbook.
- Supreme Court of the United States / Cornell Legal Information Institute. Dobbs v Jackson Women's Health Organization, 597 U.S. 215 (2022).
- Guttmacher Institute. State Bans on Abortion Throughout Pregnancy. Updated September 2026.
- The White House. Enforcing the Hyde Amendment. Executive Order, 24 January 2025.
- The White House. Memorandum on the Mexico City Policy. 24 January 2025.
- UK Parliament House of Commons Library. UK-US bilateral relationship. 31 January 2025.
- Charity Commission for England and Wales. ADF International (UK), charity no. 1173195. Accounts and annual returns, including year ending 30 June 2025.
- ProPublica Nonprofit Explorer. Alliance Defending Freedom. US Form 990 financial data for fiscal year ending June 2024.
- The Guardian, Shanti Das. ‘Extreme’ US anti-abortion group ramps up lobbying in Westminster. 6 April 2024.
- The Guardian. US anti-abortion group expands campaign in UK. 2 April 2025.
- UK Parliament. Written Question HL6542, Baroness Bennett of Manor Castle; answered 28 April 2025.
- UK Parliament. Register of All-Party Parliamentary Groups: Pro-Life. 23 February 2026 edition.
- Charity Commission for England and Wales. The Right To Life Charitable Trust, charity no. 1099319. Accounts for year ending 31 March 2025.
- Right To Life UK. About us and All-Party Parliamentary Pro-Life Group.
- European Parliamentary Forum for Sexual & Reproductive Rights. Tip of the Iceberg: Religious Extremist Funders against Human Rights for Sexuality & Reproductive Health in Europe. 2021.
- European Parliamentary Forum for Sexual & Reproductive Rights. The Next Wave: How Religious Extremism Is Reclaiming Power. 2025.
- openDemocracy. Revealed: Files expose ‘culture war’ ties between anti-abortion groups and Brexit. 2021.
- Sexual Health London. Female sterilisation. Clinical information reviewed December 2020.
Editorial note: I distinguish throughout between documented lobbying and funding, criticism made by reproductive-rights organisations, and my own interpretation of the risks posed by gradual restrictions on reproductive autonomy. I have found no evidence that ADF or another anti-abortion organisation caused the NHS female-sterilisation commissioning restriction discussed in my case.
0 comments